Orlistat News
- Research on immune system can develop new therapy for inflammation, tumors Friday, September 3, 2010 @ 5:57AMIn two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat inflammation, wounds, asthma, and malignant tumors.
- Martek Biosciences 2010 third quarter revenue increases to $117.2 million Thursday, September 2, 2010 @ 12:42AMMartek Biosciences Corporation today announced its financial results for the third quarter of fiscal 2010.
- Latest achievements in brain research and treatment for mental disorders Monday, August 30, 2010 @ 7:18AMMental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.
- David Mosser to discuss primary duty of macrophages at American Physiological Society conference Friday, August 27, 2010 @ 8:48AMThe term "macrophage" conjures images of a hungry white blood cell gobbling invading bacteria. However, macrophages do much more than that. Not only do they act as antimicrobial warriors, they also play critical roles in immune regulation and wound-healing. They can respond to a variety of cellular signals and change their physiology in response to local cues.
- GPs must cut back on medicines: NHS officials Saturday, August 7, 2010 @ 3:57AMGPs have been told to cut down on prescribing medicines as the Department of Health tries to save money, it has emerged.
- Fitness gimmicks fail to deliver Tuesday, July 27, 2010 @ 10:06AMThere are a lot of fitness gimmicks out there making big promises to its users, but these products may not bring you the same long term effects as a regular scheduled exercise routine.
- Lorcaserin: A Weight Loss Medication with less Side Effects? Sunday, July 18, 2010 @ 10:19AMAs published in this week"s edition of the New England Journal of Medicine, and as previously blogged , study of a new weight loss medication called Lorcaserin is well underway.
- Zacks Analyst Blog Highlights: Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics Thursday, July 15, 2010 @ 5:00PMCHICAGO----Zacks.com Analyst Blog features: Vivus , Roche , GlaxoSmithKline , Abbott and Orexigen Therapeutics .
- Experimental diet pill shows promise, little risk Thursday, July 15, 2010 @ 1:26PMATLANTA (AP)- An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study f...
- Diet pill lorcaserin shows promise, little risk Thursday, July 15, 2010 @ 1:14PMLorcaserin, an experimental diet pill, helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.
- Zacks Analyst Blog Highlights: Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics Thursday, July 15, 2010 @ 8:21AMZacks Analyst Blog Highlights: Vivus, Roche, GlaxoSmithKline, Abbott and Orexigen Therapeutics
- No Evidence That Popular Slimming Supplements Facilitate Weight Loss Wednesday, July 14, 2010 @ 6:45AMNew research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss beyond the placebo effect. Two studies presented at the International Congress on Obesity in Stockholm, Sweden, have found they were no more effective than the fake supplements they were compared with ...
- The globesity epidemic Monday, July 12, 2010 @ 7:32PMGlobesity – A world wide Epidemic
- New Research Finds No Evidence That Popular Slimming Supplements Facilitate Weight Loss Monday, July 12, 2010 @ 2:13PMNew research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss beyond the placebo effect.Two studies presented today (Monday) at the International Congress on Obesity in Stockholm, Sweden, have found they were no more effective than the fake supplements they were ...
- New research finds no evidence that popular slimming supplements facilitate weight loss Monday, July 12, 2010 @ 7:00AMNew research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss beyond the placebo effect.
- New research finds no evidence that popular slimming supplements facilitate weight loss Monday, July 12, 2010 @ 6:45AMNew research evaluating the effectiveness of a broad selection of popular slimming supplements sold in pharmacies and health food shops has found no evidence that any of them facilitate weight loss. Two studies presented today at the International Congress on Obesity have found they were no more effective than the fake supplements they were compared with.
- Weight loss supplements do not work, say experts Monday, July 12, 2010 @ 6:42AMSlimming supplements are a waste of time and money and should be banned, experts said last night.
- Consumers Choosing Natural Phenocal Weight Loss Aid After FDA Releases Alarming Report On Prescription Diet Pills Monday, July 12, 2010 @ 4:13AMPharmaxa Labs, the makers of the revolutionary weight loss supplement, Phenocal, are seeing healthy third quarter sales that have been partially spurred by a recent FDA warning that was issued regarding the associated risks of using some of the commonly prescribed weight-loss drugs
- If you like to tan indoors, beware melanoma Friday, July 9, 2010 @ 3:06AMOn the subject of suntans, new research at the University of Minnesota finds that people who tan indoors are 74 percent more likely to develop melanoma than those who have never tanned indoors.
- Diet drugs Wednesday, July 7, 2010 @ 7:39PMHow market in counterfeit slimming pills is booming
- From brittle bones to depression and suicide, the true costs of gastric bands (and - watch out Vanessa Feltz - you may ... Monday, July 5, 2010 @ 9:00PMBehind the celebrity glitz and apparent convenience, serious concerns are emerging about their overuse, their soaring failure rate and the lifelong complications that can result.
- Chemical that can stop you eating for pleasure is discovered by British scientists Sunday, July 4, 2010 @ 8:59PMAn appetite suppressant that takes away the desire for post-pub kebabs and calorific late-night snacks has been discovered by British scientists.
- Drug for bones helps keep breast cancer from spreading Thursday, June 10, 2010 @ 3:06AMA drug that strengthens bones also helps keep breast cancer from spreading, according to new research at Washington University in St. Louis.
- CORRECT: EMEA Urged To Open Access To Obesity Drug Studies Wednesday, June 9, 2010 @ 8:13AMCORRECT: EMEA Urged To Open Access To Obesity Drug Studies
- Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems Wednesday, June 9, 2010 @ 1:32AMThe growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes, as described in a Special Supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc.
- Lose the pounds, lose the risk: Obesity raises the risk of various illnesses and death Tuesday, June 8, 2010 @ 8:21PMAccording to a 2008 study released by the National Center for Health Statistics, more than two-thirds of U.S. adults are overweight or obese.
- Idera reports preliminary results from IMO-3100 Phase 1 clinical trial for autoimmune, inflammatory diseases Tuesday, June 8, 2010 @ 8:47AMIdera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all ...
- La Jolla Institute scientist finds protein key to insulin secretion Tuesday, June 8, 2010 @ 3:32AMIf you think of diabetes onset like an elaborate molecular drama, then a research team led by a La Jolla Institute scientist has unmasked a previously unknown cellular player, which is critical to proper insulin secretion. "Defective insulin secretion is a hallmark of both type 1 and type 2 diabetes," said Catherine Hedrick, Ph.D., a scientist at the La Jolla Institute for Allergy & Immunology ...
- Genentech reports results from Phase III study of Avastin in women with advanced ovarian cancer Monday, June 7, 2010 @ 8:11AMGenentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening ...
- FDA Issues Warning On Xenical, Alli Thursday, May 27, 2010 @ 3:55PMThe FDA has new warnings on weight loss drugs Xenical and Alli. These medicines are big money makers. Each made more than $300 million worldwide just in the past year. But a rare and serious problem, perhaps related to these weight loss drugs, could change how people look at these products.
- FDA Warning Labels Not Needed for mirafit fbcx(R) Weight Loss Supplement Thursday, May 27, 2010 @ 3:15PMDETROIT, MI--(Marketwire - May 27, 2010) - Yesterday, the U.S. Food & Drug Administration announced it is requiring a new warning about potential liver injury to be placed on the weight-loss drugs Xenical and Alli.
- FDA Warning Labels Not Needed for mirafit fbcx(R) Weight Loss Supplement Thursday, May 27, 2010 @ 3:05PMYesterday, the U.S. Food & Drug Administration announced it is requiring a new warning about potential liver injury to be placed on the weight-loss drugs Xenical and Alli. read more
- FDA Warning Labels Not Needed for mirafit fbcx(R) Weight Loss Supplement Thursday, May 27, 2010 @ 2:58PMDETROIT, MI--(Marketwire - 05/27/10) - Yesterday, the U.S. Food & Drug Administration announced it is requiring a new warning about potential liver injury to be placed on the weight-loss drugs Xenical and Alli. These medications used for weight-loss that contain different strengths of the same active ingredient, orlistat, a derivative of lipstatin, an inhibitor of pancreatic enzymes that ...
- FDA Warning for Obesity Drugs Thursday, May 27, 2010 @ 2:56PMThe FDA recently issued a warning regarding the possibility of rare cases of liver injury occurring with the use of weight loss drugs Xenical and Alli.
- Alli, Xenical Get Warnings For Severe Liver Injury Thursday, May 27, 2010 @ 2:19PMThe safety labels for Xenical, and its over-the-counter counterpart, Alli, are being modified to include information about potential rare occurrences of severe liver injury in patients, the U.S. Food & Drug Administration (FDA) announced yesterday. The popular weight loss medications have been used by an estimated 40 million people worldwide. Both Xenical and Alli contain [...]
- FDA: Rare Cases Of Liver Injury Reported With Use Of Xenical, Alli Thursday, May 27, 2010 @ 11:27AMThe U.S. Food and Drug Administration advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli. The FDA has approved a revised label for the prescription drug Xenical. The agency is working with the manufacturer of Alli on label revisions to reflect this rare ...
- FDA: Alli, Xenical Linked to Rare Liver Injury Wednesday, May 26, 2010 @ 5:22PMFDA: The labels for the popular weight loss products Alli and Xenical must warn of a very small risk of severe liver injury. Worldwide, there have been 13 cases including two deaths.
- Weight Loss Medication Xenical, Alli (orlistat) Rare Cases Of Liver Injury Announcement By FDA Wednesday, May 26, 2010 @ 5:16PMThere may be rare occurrences of severe liver injury in patients taking active ingredient orlistat, marketed as Xenical or Alli - a weight-loss medication, says the Food and Drug Administration (FDA). The FDA approved a revised label for Xenical, a prescription drug. The FDA says it is working with the manufacturers of Alli regarding label revisions to reflect this "rare occurrence". Active ...
- U.S. warns of liver risk with Glaxo, Roche diet drugs Wednesday, May 26, 2010 @ 4:05PMWeight-loss drugs from GlaxoSmithKline PLC and Roche Holding AG will carry new warnings about rare reports of liver injury, U.S. health officials said on Wednesday.
- Rare Cases of Liver Damage Tied to Weight-Loss Drug Wednesday, May 26, 2010 @ 4:03PMWEDNESDAY, May 26 (HealthDay News) -- Responding to reports of rare but sometimes severe cases of liver damage, U.S. health officials on Wednesday announced revised labels for a widely used weight-loss drug.
- (AFX UK Focus) 2010-05-26 19:53 UPDATE 3-US warns of liver risk with Glaxo, Roche diet drugs Wednesday, May 26, 2010 @ 3:20PMBy Lisa Richwine
- FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli Wednesday, May 26, 2010 @ 2:12PMSILVER SPRING, Md., May 26 /PRNewswire-USNewswire/ -- The U.S.
- GSK Consumer Healthcare to Update alli Label as FDA Completes Safety Review of Orlistat Wednesday, May 26, 2010 @ 2:09PMread more
- Xenical, Alli labels warn of liver injury Wednesday, May 26, 2010 @ 1:08PMWASHINGTON, May 26 (UPI) -- The U.S. Food and Drug Administration has approved a new label for Xenical and Alli to include information about rare, but possible, severe liver injury.
- FDA Warns On Diet Drugs Xenical, Alli Wednesday, May 26, 2010 @ 1:07PMFDA Warns On Diet Drugs Xenical, Alli
- FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli Wednesday, May 26, 2010 @ 12:50PMread more
- Health: Cut sugar to reduce blood pressure Tuesday, May 25, 2010 @ 2:18AMREMEMBER when you were told to cut the salt to reduce the high blood pressure? Well, now you’ll need to take another piece of advice from a hot new study that has found its way into the Archives Of Internal Medicine, one of the world’s leading medical journals. Cut the sugar as well.
- Smoking cessation treatments effective and safe for people with schizophrenia Friday, May 21, 2010 @ 8:10AMIn a study published today in the journal Addiction, researchers have determined that treatment for smoking dependence is as effective among people with severe mental illnesses as it is for the general population. Importantly, they also found that offering such treatments does not appear to cause deterioration in mental health.
- United Spinal Association and ICS co-sponsor first annual conference to empower women with disabilities Saturday, May 15, 2010 @ 7:38AMUnited Spinal Association and Independence Care System (ICS), are co-sponsoring the first annual conference to improve the lives, health, and well-being of women with disabilities.
- Rise in weight-loss pills as diet advice goes unheeded Friday, May 14, 2010 @ 7:16PMThe number of prescription weight-loss drugs being given out in England is continuing to rise as doctors struggle to provide specialist advice on diet and exercise to overweight patients.